Dipak Sarker

Dr. Dipak Sarker

University of Brighton, UK
+1
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
Dipak SarkerDipak Sarker
Dipak Sarker
Nanoemulsions, usually spherical, are a group of dispersed particles used for pharmaceutical and biomedical aids and vehicles that show great promise for the future of cosmetics, diagnostics, drug therapies and biotechnologies. They exist in a wide variety of forms that are dictated by the particle components. Nanoemulsions are generally considered to be in the size range of less than and around 100 nm in diameter. The particles can exist as water-in-oil and oil-inwater forms, where the core of the particle is either water or oil, respectively. More complex variations also exist but these are often larger. The longer-term properties of the particle are dependent on the composition of the adsorbed material lying at the dispersed droplet interface with the dispersion medium. This has an impact on the partitioning and extraction of droplet contents. Thermodynamically stable particles are characterized by having a very low surface tension and this produces a very large surface area. Nanoemulsions can also include small meta-stable very small-scale emulsions; here the surface properties and chemistry can strongly influence behaviour. Processing, storage and formulation composition can also have an impact on the longevity of a pharmaceutical preparation. Some revolutionary new nanoemulsion droplets based on fluorinated compounds are finding a number of widespread biomedical roles and applications. Developments in nanoemulsion technology are likely to lead to a much greater use of this medium in future pharmaceuticals.

1 December 2002 in Langmuir
Verified
Journal Article
Closed access
SRSalima Rafaï
Salima Rafaï
Dipak SarkerDipak Sarker
Dipak Sarker
VBVance Bergeron
Vance Bergeron
JMJacques Meunier
Jacques Meunier
DBDaniel Bonn
Daniel Bonn

1 August 2010 in Food Hydrocolloids
Verified
Journal Article
Closed access
Carla Daniela Di MattiaCarla Daniela Di Mattia
Carla Daniela Di Mattia
GSGiampiero Sacchetti
Giampiero Sacchetti
DMDino Mastrocola
Dino Mastrocola
Dipak SarkerDipak Sarker
Dipak Sarker
PPPaola Pittia
Paola Pittia

1 December 1996 in Food Hydrocolloids
Verified
Journal Article
Closed access
RWR. Wüstneck
R. Wüstneck
JKJ. Krägel
J. Krägel
Reinhard MillerReinhard Miller
Reinhard Miller
VFV.B. Fainerman
V.B. Fainerman
PWP.J. Wilde
P.J. Wilde
DCD.C. Clark
D.C. Clark

1 July 2003 in Drug Discovery Today
Verified
Journal Article
Closed access
DHDavid N. Howbrook
David N. Howbrook
AVAnne M. van der Valk
Anne M. van der Valk
MOMeg C. O'Shaughnessy
Meg C. O'Shaughnessy
Dipak SarkerDipak Sarker
Dipak Sarker
SBSimon C. Baker
Simon C. Baker
ALAndrew W. Lloyd
Andrew W. Lloyd

1 February 1995 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Dipak SarkerDipak Sarker
Dipak Sarker
Peter WildePeter Wilde
Peter Wilde
DCDavid C. Clark
David C. Clark